Roche Holding Ltd ADR (Sponsored)

(RHHBY)

By |

Profile

Roche is a Swiss biopharmaceutical and diagnostic company. The firm's best-selling pharmaceutical products include a variety of oncology therapies from acquired partner Genentech, and its diagnostics group was bolstered by the acquisition of Ventana in 2008. Oncology products account for 60% of pharmaceutical sales, and professional diagnostics for more than half of diagnostic-related sales.

Contact Information

Website: www.roche.com
Email: investor.relations@roche.com
Main Phone: +41 616881111
Address: c/o F. Hoffmann-La Roche AG
Address 2: Grenzacherstrasse 124
City / Town: Basel
Country: CHE
Postal Code: CH-4070

Issuer Information

Exchange: OTCQX
Employees: 94442
NAICS: Pharmaceutical Preparation Manufacturing(325412)


Gathering Data... Please wait

Profile

Roche is a Swiss biopharmaceutical and diagnostic company. The firm's best-selling pharmaceutical products include a variety of oncology therapies from acquired partner Genentech, and its diagnostics group was bolstered by the acquisition of Ventana in 2008. Oncology products account for 60% of pharmaceutical sales, and professional diagnostics for more than half of diagnostic-related sales.

Contact Information

Website: www.roche.com
Email: investor.relations@roche.com
Main Phone: +41 616881111
Address: c/o F. Hoffmann-La Roche AG
Address 2: Grenzacherstrasse 124
City / Town: Basel
Country: CHE
Postal Code: CH-4070

Issuer Information

Exchange: OTCQX
Employees: 94442
NAICS: Pharmaceutical Preparation Manufacturing(325412)
$ 33.64 $ -0.8299 (-2.41%)
Last Price 33.64 Change $ -0.8299 Change % -2.41 Tick N/A
Bid 0. Bid Size 0.00 Ask 0. Ask Size 0.00
Open 33.57 High 33.83 Low 33.49 Prev Close 34.47
Last Trade Volume 1.3 mi 52 Wk Hi 35.90 52 Wk Low 28.74
Market Cap 229.8 bi Ex-Div Date Div Rate 0.68 Yield 2.0170
Shares 6,830,797,784.00 EPS (TTM) 1.55 PE Ratio 21.70 Exchange OTCQX
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 35 38 38 35
Low Target Price Estimate 32 35 35 32
Mean Target Price Estimate 33.5 36.5 36.5 33.5
Standard Deviation 2.12 2.12 2.12 2.12
Date of Most Recent Estimate 05/30/18 04/27/18 04/27/18 05/30/18
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 3 3 3 3
Moderate Buy 0 0 0 0
Hold 2 2 2 2
Moderate Sell 0 0 0 0
Strong Sell 2 2 2 2
Mean Rec. 2.71 2.71 2.71 2.71